Composition for therapeutic use, including an organic lipid phase and a rare-earth radioisotope complex
US9579409B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 17, 2013 |
| Grant date | Feb 28, 2017 |
| Priority date | — |
| Expiry date | Jul 17, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a therapeutic composition including a complex having the following formula (1), including a rare-earth radioisotope in ionic form, said complex being solubilized in an organic lipophilic phase: [M(L)3] in which: M denotes the rare-earth radioisotope in ionic form, and L denotes a tropolone ligand or a ligand derived from tropolone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.